Kentaro Nagaoka Selected Research

Kentaro Nagaoka Research Topics

Disease

10	Pneumonia (Pneumonitis) 04/2024 - 08/2013
6	Infections 10/2023 - 06/2013
5	COVID-19 01/2024 - 12/2021
5	Neoplasms (Cancer) 01/2024 - 01/2013
4	Bacteremia 10/2023 - 01/2016
4	Inflammation (Inflammations) 02/2023 - 12/2011
3	Abscess 05/2024 - 06/2013
3	Body Weight (Weight, Body) 12/2023 - 12/2016
3	Flushing 01/2021 - 08/2003
2	Mastitis 05/2024 - 12/2014
2	Sepsis (Septicemia) 03/2024 - 01/2023
2	Bacterial Infections (Bacterial Infection) 01/2023 - 08/2009
2	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 01/2022
2	Periodontitis 01/2020 - 04/2013
2	Ventilator-Associated Pneumonia 09/2013 - 08/2013
1	Febrile Neutropenia 05/2024
1	Lung Injury 04/2024
1	Hypotension (Low Blood Pressure) 01/2024
1	Breakthrough Infections 01/2024
1	Oral Lichen Planus 12/2023
1	Neuroblastoma 11/2023
1	Dyslipidemias (Dyslipidemia) 02/2023
1	Invasive Fungal Infections 01/2023
1	Lupus Nephritis 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Severe Acute Respiratory Syndrome 12/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Erythema 12/2019
1	Obesity 04/2019
1	Hypercholesterolemia 04/2019
1	Disease Progression 02/2019
1	Fever (Fevers) 02/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2017

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2003
4	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 01/2016
4	Progesterone FDA LinkGeneric 01/2021 - 12/2007
3	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2023
3	Messenger RNA (mRNA)IBA 04/2024 - 08/2003
3	Particulate MatterIBA 04/2024 - 01/2023
3	Daptomycin FDA Link 04/2023 - 06/2013
3	Vancomycin FDA LinkGeneric 04/2023 - 02/2017
3	CytokinesIBA 01/2023 - 12/2011
3	VaccinesIBA 09/2022 - 12/2021
3	Azithromycin (Zithromax)FDA LinkGeneric 02/2019 - 08/2013
2	ORALIT (ORS)IBA 05/2024 - 01/2024
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2024 - 02/2019
2	Amino Acids FDA Link 05/2024 - 08/2009
2	Indicators and Reagents (Reagents)IBA 03/2024 - 01/2023
2	AntioxidantsIBA 01/2024 - 11/2023
2	Interleukin-6 (Interleukin 6)IBA 01/2024 - 01/2022
2	Leukocidins (Leukocidin)IBA 10/2023 - 01/2020
2	Interferon Type IIBA 01/2022 - 01/2022
2	SteroidsIBA 01/2021 - 02/2019
2	Hormones (Hormone)IBA 01/2021 - 12/2016
2	MacrolidesIBA 02/2019 - 01/2019
2	CorticosteroneIBA 01/2018 - 12/2007
2	ProlactinIBA 04/2008 - 12/2007
2	Adrenocorticotropic Hormone (ACTH)FDA Link 04/2008 - 12/2007
1	C-Reactive ProteinIBA 05/2024
1	Proline (L-Proline)FDA Link 05/2024
1	Alanine (L-Alanine)FDA Link 05/2024
1	Valine (L-Valine)FDA Link 05/2024
1	CreatinineIBA 01/2024
1	isoquercitrinIBA 01/2024
1	RNA (Ribonucleic Acid)IBA 12/2023
1	Taurine FDA Link 11/2023
1	TeicoplaninIBA 04/2023
1	Linezolid (Zyvox)FDA Link 04/2023
1	LipidsIBA 02/2023
1	SuspensionsIBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	polyglucosanIBA 01/2023
1	fisetinIBA 01/2022
1	casirivimab and imdevimab drug combinationIBA 01/2022
1	mRNA VaccinesIBA 12/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	Apoprotein(a) (Apolipoprotein (a))IBA 01/2020
1	Hemolysin Proteins (Hemolysins)IBA 01/2020
1	Surface-Active Agents (Surfactants)IBA 01/2020
1	Keratin-7 (Cytokeratin 7)IBA 01/2020
1	Keratin-20 (Cytokeratin 20)IBA 01/2020
1	Immunoglobulin E (IgE)IBA 12/2019
1	PF-670462IBA 12/2019
1	A-factor (Streptomyces)IBA 12/2019
1	glutaryl-coenzyme A (glutaryl-CoA)IBA 04/2019
1	Fluvastatin FDA Link 04/2019
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 04/2019
1	Tetracycline (Achromycin)FDA LinkGeneric 02/2019
1	sultamicillin (ampicillin-sulbactam)FDA LinkGeneric 02/2019
1	FluoroquinolonesIBA 02/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	CholesterolIBA 09/2017

Therapy/Procedure

4	Therapeutics 04/2023 - 01/2016
2	Aftercare (After-Treatment) 01/2022 - 02/2019
2	Oral Hygiene (Dental Hygiene) 01/2020 - 02/2014
1	Salvage Therapy 04/2023